[Federal Register Volume 89, Number 93 (Monday, May 13, 2024)]
[Notices]
[Pages 41442-41443]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-10301]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Board of Scientific Counselors, National Center 
for Injury Prevention and Control

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of open and closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting for the Board of Scientific Counselors, National 
Center for Injury Prevention and Control (BSC, NCIPC). This meeting 
will take place in person and virtually and is partially open to the 
public.

DATES: The meeting will be held on June 5, 2024, from 1 p.m. to 4 p.m., 
EDT (Closed); and June 6, 2024, from 10 a.m. to 3:30 p.m., EDT (Open). 
The public comment period will be at the end of the open session of the 
meeting on June 6, 2024, from 3:10 p.m. to 3:25 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention, Chamblee Campus, 
Building 106, Conference Room 1-B, 4770 Buford Highway NE, Atlanta, 
Georgia 30341. The conference room will have seating for approximately 
100 people for the open session of the meeting.
    Please note that the meeting location is a federal facility and in-
person access is limited to United States citizens unless prior 
authorizations, taking up to 30 to 60 days, have been made. Visitors 
must follow all directions for access to CDC facilities. Directions for 
visitors to CDC, including safety requirements related to COVID-19, are 
available at https://www.cdc.gov/screening/visitors.html.
    If you wish to attend the open session of the meeting in person, 
please submit a request by email to Mrs. Tonia Lindley at 
[email protected] at least 5 business days in advance of the meeting.
    If you wish to attend the open session of the meeting virtually, 
please register in advance by accessing the link at: https://cdc.zoomgov.com/webinar/register/WN_X5RXABmES3u_tsbMJdSJkg. 
Instructions to access the Zoom virtual meeting will be provided in the 
link following registration.

FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D., 
Designated Federal Officer, Board of Scientific Counselors, National 
Center for Injury Prevention and Control, Centers for Disease Control 
and Prevention, 4770 Buford Highway NE, Mailstop S-1069, Atlanta, 
Georgia 30341. Telephone: (404) 718-8330; Email: [email protected].

SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above 
will be closed to the public in accordance with provisions set forth in 
section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of 
the Director, Office of Strategic Business Initiatives, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention 
(CDC), pursuant to 5 U.S.C. 1009(d) (Pub. L. 92-463, as amended).
    Purpose: The Board of Scientific Counselors, National Center for 
Injury Prevention and Control (BSC, NCIPC) will: (1) conduct, 
encourage, cooperate with, and assist other appropriate public health 
authorities, scientific institutions, and scientists in the conduct of 
research, investigations, experiments, demonstrations, and studies 
relating to the causes and strategies related to the prevention of 
injury, overdose, and violence; (2) assist States and other entities in 
preventing intentional and unintentional injuries, and to promote 
health and well-being; and (3) make recommendations of grants and 
cooperative agreements for research and prevention activities related 
to injury, overdose, and violence. The BSC, NCIPC makes recommendations 
regarding policies, strategies, objectives, and priorities and reviews 
progress toward injury, overdose, and violence prevention. The Board 
also provides advice on the appropriate balance of intramural and 
extramural research and provides guidance on the needs, structure, 
progress, and performance of intramural programs. Further, the Board 
provides guidance on extramural scientific program matters. 
Additionally, the Board provides second-level scientific and 
programmatic review of applications for research grants, cooperative 
agreements, and training grants related to injury, overdose, and 
violence prevention, and recommends approval of projects that merit 
further consideration for funding support. The Board also provides 
feedback and input on strategic plans, resources, and priority 
publications related to injury, overdose, and violence prevention.
    Matters to be Considered: The closed session of the meeting (Day 1) 
will focus on the secondary peer review of extramural research grant 
applications received in response to three (3) Notices of Funding 
Opportunity: RFA-CE-22-003--``Rigorously Evaluating Programs and 
Policies to Prevent Child Sexual Abuse (CSA)''; RFA-CE-24-012--
``Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose 
(R01)''; and RFA-CE-24-030--``Research Grants for Preventing

[[Page 41443]]

Violence and Violence Related Injury (R01).'' The open session of the 
meeting (Day 2) will include discussions on Enhancing CDC's Efforts to 
Promote Mental Health and Reduce Overdose and Suicide: CDC's New 
Behavioral Health Coordinating Unit; the 2024 National Strategy for 
Suicide Prevention and Action Plan; Updated Sexual Violence Research 
Priorities; Leveraging High-Quality Data from the Violence Against 
Children and Youth Survey to Demonstrate Reductions in Population 
Prevalence of Violence against Children; and Division of Overdose 
Prevention Portfolio Review, 2018-2023: Informing the 2025 Update to 
the Overdose Prevention Research Priorities. Agenda items are subject 
to change as priorities dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-10301 Filed 5-10-24; 8:45 am]
BILLING CODE 4163-18-P